The outbreak of the Coronavirus disease 2019 (COVID-19) pandemic has caused worldwide problems in the care of cancer patients. In particular, the therapy of cancer patients, both outpatient and inpatient, has been substantially impacted by major restrictions due to the isolation and hygiene measures. Not only the restriction of treatment under pandemic conditions but also a SARS-CoV-2 infection itself poses a risk for cancer patients.

For more information on 'Cancer & Covid: Prevention and Treatment with Monoclonal Antibodies (MoABs)' we invite you to read a report published on the Cancerworld website. Click here to access the full article.

The aim of this session is to spread awareness and knowledge among HCPs on vaccination efficacy, COVID outcome, COVID treatment and prophylaxis with moAB in haematological patients.

The scientific report of this webinar is available on the Cancerworld website. Click here to access the full article.